Gemcitabine as a single agent in the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma.
about
Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scid mice.Gemcitabine as a single agent in the treatment of relapsed or refractory low-grade non-Hodgkin's lymphoma.Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma.Gemcitabine, etoposide, cisplatin, and dexamethasone in patients with refractory or relapsed non-Hodgkin's lymphoma.Rituximab, gemcitabine, cisplatin, and dexamethasone in patients with refractory or relapsed aggressive B-cell lymphoma.Study on effectiveness of gemcitabine, dexamethasone, and cisplatin (GDP) for relapsed or refractory AIDS-related non-Hodgkin's lymphoma.Efficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed/refractory lymphoma: a prospective multi-center phase II study by the Puget Sound Oncology ConsortiumThe histone deacetylase inhibitor LBH589 (panobinostat) modulates the crosstalk of lymphocytes with Hodgkin lymphoma cell lines.A phase 2 study of epothilone B analog BMS-247550 (NSC 710428) in patients with relapsed aggressive non-Hodgkin lymphomasCurrent trends in large cell lymphoma.Pixantrone: a promising drug in the treatment of non-Hodgkin lymphomas.Lenalidomide: a synthetic compound with an evolving role in cancer management.Treatment of the elderly patient with diffuse large B cell lymphoma.Pixantrone-rituximab versus gemcitabine-rituximab in relapsed/refractory aggressive non-Hodgkin lymphoma.A retrospective analysis of combination chemotherapy consisting cyclophosphamide, vincristine, prednisolone and procarbazine (C-MOPP) for pretreated aggressive non-Hodgkin lymphoma.Rituximab, gemcitabine and oxaliplatin: an effective salvage regimen for patients with relapsed or refractory B-cell lymphoma not candidates for high-dose therapy.Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma.Biweekly dose-dense gemcitabine-oxaliplatin and dexamethasone for relapsed/refractory aggressive non-Hodgkin lymphoma: A multicenter, single-arm, phase II trial.
P2860
Q24813078-637276D5-4E79-4EC9-BFEE-D62B3CB70D21Q33337520-AEDFD19E-4F47-4F28-AFEA-F101FEA13543Q33365711-DF7DC6B3-C636-4475-BA86-ED029FC7C634Q33383608-5043B3FA-1007-4300-A990-564D8525FD66Q33400583-FA0933A1-12ED-403B-B9E9-4C684127061CQ33402306-F3460DA8-0F5A-4F27-B7B8-01D58F53ADD7Q34477705-63132D74-1488-40CB-A2A6-7207438C42C8Q35053177-AE246D53-63FB-44BE-9556-1A267637F376Q35096335-8C6971A5-0F78-4D8B-8DF4-C71DE0752CE7Q35545076-2745B0AE-4A2B-4C1F-89C7-33A6EE7CC132Q37486763-196079A0-BD3E-48F6-8720-8D2A64E58ABFQ37791617-55B64728-8B62-422C-B29C-66718F7B6C97Q37998553-0F30B40C-F62E-46E7-815D-FAD4F220B5AEQ38878964-1BB21926-9A66-4F6F-A48B-8325C529FD00Q39839569-652E2D1B-8770-47C8-8633-A7B5B3CD195DQ43814680-382A266D-21A4-412C-A680-6B2EA88633FCQ53077918-508A6BE7-E791-43BD-85FE-DA5F97156018Q53153689-8DFACA04-D3AC-407F-A7EA-3448384CF3BF
P2860
Gemcitabine as a single agent in the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Gemcitabine as a single agent ...... essive non-Hodgkin's lymphoma.
@ast
Gemcitabine as a single agent ...... essive non-Hodgkin's lymphoma.
@en
Gemcitabine as a single agent ...... essive non-Hodgkin's lymphoma.
@nl
type
label
Gemcitabine as a single agent ...... essive non-Hodgkin's lymphoma.
@ast
Gemcitabine as a single agent ...... essive non-Hodgkin's lymphoma.
@en
Gemcitabine as a single agent ...... essive non-Hodgkin's lymphoma.
@nl
prefLabel
Gemcitabine as a single agent ...... essive non-Hodgkin's lymphoma.
@ast
Gemcitabine as a single agent ...... essive non-Hodgkin's lymphoma.
@en
Gemcitabine as a single agent ...... essive non-Hodgkin's lymphoma.
@nl
P2093
P1476
Gemcitabine as a single agent ...... essive non-Hodgkin's lymphoma.
@en
P2093
G Bonadonna
L Truemper
M R Nowrousian
N Niederle
S Buksmaui
W Hiddemann
P304
P356
10.1200/JCO.1999.17.12.3786
P407
P577
1999-12-01T00:00:00Z